{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:22:01Z","timestamp":1781518921782,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113630","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T22:17:55Z","timestamp":1731709075000},"page":"113630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["Nintedanib attenuates NLRP3 inflammasome-driven liver fibrosis by targeting Src signaling"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8307-1039","authenticated-orcid":false,"given":"Ye-Ting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-4933","authenticated-orcid":false,"given":"Xue-Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113630_b0005","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2024.113630_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin. Liver Dis."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.113630_b0015","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis -- from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.113630_b0020","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.clinre.2015.06.015","article-title":"Reversibility of liver fibrosis","volume":"39","author":"Sun","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.113630_b0025","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2024.113630_b0030","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1007\/s10620-023-08101-1","article-title":"Anlotinib attenuates liver fibrosis by regulating the transforming growth factor beta1\/smad3 signaling pathway","volume":"68","author":"Wu","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2024.113630_b0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.1840150211","article-title":"Isolated hepatic lipocytes and kupffer cells from normal human liver: morphological and functional characteristics in primary culture","volume":"15","author":"Friedman","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2024.113630_b0040","doi-asserted-by":"crossref","first-page":"e13158","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via hif-1alpha\/slc7a11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.intimp.2024.113630_b0045","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1039\/D0FO00660B","article-title":"Pelargonidin ameliorates ccl(4)-induced liver fibrosis by suppressing the ros-nlrp3-il-1beta axis via activating the nrf2 pathway","volume":"11","author":"Shi","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2024.113630_b0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2024.113630_b0055","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/gutjnl-2019-318372","article-title":"Rilpivirine attenuates liver fibrosis through selective stat1-mediated apoptosis in hepatic stellate cells","volume":"69","author":"Marti-Rodrigo","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2024.113630_b0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2024.113630_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2014.10.013","article-title":"Hypoxia-inducible factor-1alpha in hepatic fibrosis: a promising therapeutic target","volume":"108","author":"Zhan","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.intimp.2024.113630_b0070","first-page":"737","article-title":"Reversibility of liver fibrosis","volume":"9","author":"Brenner","year":"2013","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"10.1016\/j.intimp.2024.113630_b0075","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"Nlrp3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2024.113630_b0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","article-title":"Emerging activators and regulators ofinflammasomes and pyroptosis","volume":"40","author":"Xue","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2024.113630_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115861","article-title":"Nlrp3 inflammasome in hepatic diseases: a pharmacological target","volume":"217","author":"Ramos-Tovar","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113630_b0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/iub.1348","article-title":"Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulatingnlrp 3 inflammasome pathway","volume":"67","author":"Wu","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.intimp.2024.113630_b0095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fphar.2020.00200","article-title":"Calcipotriol inhibits nlrp3 signal through yap1 activation to alleviate cholestatic liver injury and fibrosis","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113630_b0100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2024.113630_b0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.18632\/oncotarget.13796","article-title":"Chenodeoxycholic acid activates nlrp3 inflammasome and contributes to cholestatic liver fibrosis","volume":"7","author":"Gong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.113630_b0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.phrs.2016.11.040","article-title":"Potentiation of hepatic stellate cell activation by extracellular atp is dependent on p2x7r-mediated nlrp3 inflammasome activation","volume":"117","author":"Jiang","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.113630_b0115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.gendis.2021.12.006","article-title":"Mechanisms of nlrp3 inflammasome-mediated hepatic stellate cell activation: therapeutic potential for liver fibrosis","volume":"10","author":"Charan","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.intimp.2024.113630_b0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.113.208223","article-title":"Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis","volume":"349","author":"Wollin","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2024.113630_b0125","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2024.113630_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107798","article-title":"Idiopathic pulmonary fibrosis: disease mechanisms and drug development","volume":"222","author":"Spagnolo","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2024.113630_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/3867198","article-title":"Effects of nintedanib in an animal model of liver fibrosis","volume":"2020","author":"Wollin","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2024.113630_b0140","doi-asserted-by":"crossref","first-page":"44545","DOI":"10.1038\/srep44545","article-title":"Tyrosine kinase inhibitor bibf1120 ameliorates inflammation, angiogenesis and fibrosis in ccl(4)-induced liver fibrogenesis mouse model","volume":"7","author":"Ozturk","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.113630_b0145","first-page":"72","article-title":"Clodronate-nintedanib-loaded exosome-liposome hybridization enhances the liver fibrosis therapy by inhibiting kupffer cell activity","volume":"1","author":"Ji","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.intimp.2024.113630_b0150","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/ijms17060972","article-title":"Role of receptor tyrosine kinase signaling in renal fibrosis","volume":"17","author":"Liu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113630_b0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000509670","article-title":"Synergistic inhibition of renal fibrosis by nintedanib and gefitinib in a murine model of obstructive nephropathy","volume":"7","author":"Feng","year":"2021","journal-title":"Kidney Dis."},{"key":"10.1016\/j.intimp.2024.113630_b0160","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1111\/jcmm.16518","article-title":"Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis","volume":"25","author":"Liu","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.intimp.2024.113630_b0165","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/jcmm.13206","article-title":"Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the src pathway","volume":"21","author":"Li","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.intimp.2024.113630_b0170","first-page":"7","article-title":"Interaction of src and alpha-v integrin regulates fibroblast migration and modulates lung fibrosis in a preclinical model of lung fibrosis","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.113630_b0175","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/molecules23081974","article-title":"Protective effects of nintedanib against polyhexamethylene guanidine phosphate-induced lung fibrosis in mice","volume":"23","author":"Kim","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113630_b0180","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1038\/s41598-017-09349-0","article-title":"Src-dependent egfr transactivation regulates lung inflammation via downstream signaling involving erk1\/2, pi3kdelta\/akt and nfkappab induction in a murine asthma model","volume":"7","author":"El-Hashim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.113630_b0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2015.02.029","article-title":"Egfr inhibition protects cardiac damage and remodeling through attenuating oxidative stress in stz-induced diabetic mouse model","volume":"82","author":"Liang","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.intimp.2024.113630_b0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cbin.11230","article-title":"Tweak promotes hepatic stellate cell migration through activating egfr\/src and pi3k\/akt pathways","volume":"44","author":"Zhang","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.intimp.2024.113630_b0195","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.1320294111","article-title":"Irak-1 bypasses priming and directly links tlrs to rapid nlrp3 inflammasome activation","volume":"111","author":"Lin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2024.113630_b0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of nlrp3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.113630_b0205","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.4049\/jimmunol.175.11.7611","article-title":"Potentiation of caspase-1 activation by the p2x7 receptor is dependent on tlr signals and requires nf-kappab-driven protein synthesis","volume":"175","author":"Kahlenberg","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.113630_b0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2024.113630_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173982","article-title":"Carvacrol alleviates liver fibrosis by inhibiting trpm7 and modulating the mapk signaling pathway","volume":"898","author":"Cai","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113630_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110251","article-title":"Edaravone protects against liver fibrosis progression via decreasing the il-1beta secretion of macrophages","volume":"368","author":"Zhao","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2024.113630_b0225","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s41423-019-0318-x","article-title":"Jagged1-mediated myeloid notch1 signaling activates hsf1\/snail and controls nlrp3 inflammasome activation in liver inflammatory injury","volume":"17","author":"Jin","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.113630_b0230","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.274.24.17209","article-title":"Erbb receptor-induced activation of stat transcription factors is mediated by src tyrosine kinases","volume":"274","author":"Olayioye","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.113630_b0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.pharmtox.44.101802.121440","article-title":"Erbb receptors: directing key signaling networks throughout life","volume":"44","author":"Holbro","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924021520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T04:25:52Z","timestamp":1733977552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924021520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S1567576924021520"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113630","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nintedanib attenuates NLRP3 inflammasome-driven liver fibrosis by targeting Src signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113630"}}